pubmed-article:18543281 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18543281 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
pubmed-article:18543281 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:18543281 | lifeskim:mentions | umls-concept:C0138741 | lld:lifeskim |
pubmed-article:18543281 | lifeskim:mentions | umls-concept:C0475387 | lld:lifeskim |
pubmed-article:18543281 | lifeskim:mentions | umls-concept:C0475388 | lld:lifeskim |
pubmed-article:18543281 | lifeskim:mentions | umls-concept:C0681698 | lld:lifeskim |
pubmed-article:18543281 | lifeskim:mentions | umls-concept:C1414461 | lld:lifeskim |
pubmed-article:18543281 | lifeskim:mentions | umls-concept:C0205092 | lld:lifeskim |
pubmed-article:18543281 | lifeskim:mentions | umls-concept:C1306673 | lld:lifeskim |
pubmed-article:18543281 | lifeskim:mentions | umls-concept:C1521733 | lld:lifeskim |
pubmed-article:18543281 | lifeskim:mentions | umls-concept:C0332185 | lld:lifeskim |
pubmed-article:18543281 | pubmed:issue | 13 | lld:pubmed |
pubmed-article:18543281 | pubmed:dateCreated | 2008-8-19 | lld:pubmed |
pubmed-article:18543281 | pubmed:abstractText | Early detection of small volume prostate cancer (PCa) has led to the concept of focal therapy to treat in an organ-sparing manner. We evaluated trends in pathologic staging among patients with localized PCa undergoing radical prostatectomy (RP), defining the frequency of unilateral cancers during 1988-1995, 1996-2000 and 2001-2006. | lld:pubmed |
pubmed-article:18543281 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18543281 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18543281 | pubmed:language | eng | lld:pubmed |
pubmed-article:18543281 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18543281 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18543281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18543281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18543281 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18543281 | pubmed:month | Sep | lld:pubmed |
pubmed-article:18543281 | pubmed:issn | 1097-0045 | lld:pubmed |
pubmed-article:18543281 | pubmed:author | pubmed-author:MoulJudd WJW | lld:pubmed |
pubmed-article:18543281 | pubmed:author | pubmed-author:PolascikThoma... | lld:pubmed |
pubmed-article:18543281 | pubmed:author | pubmed-author:MaddenJohn... | lld:pubmed |
pubmed-article:18543281 | pubmed:author | pubmed-author:SunLeonL | lld:pubmed |
pubmed-article:18543281 | pubmed:author | pubmed-author:MouravievVlad... | lld:pubmed |
pubmed-article:18543281 | pubmed:author | pubmed-author:MayesJanice... | lld:pubmed |
pubmed-article:18543281 | pubmed:copyrightInfo | (c) 2008 Wiley-Liss, Inc. | lld:pubmed |
pubmed-article:18543281 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18543281 | pubmed:day | 15 | lld:pubmed |
pubmed-article:18543281 | pubmed:volume | 68 | lld:pubmed |
pubmed-article:18543281 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18543281 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18543281 | pubmed:pagination | 1380-6 | lld:pubmed |
pubmed-article:18543281 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:18543281 | pubmed:meshHeading | pubmed-meshheading:18543281... | lld:pubmed |
pubmed-article:18543281 | pubmed:meshHeading | pubmed-meshheading:18543281... | lld:pubmed |
pubmed-article:18543281 | pubmed:meshHeading | pubmed-meshheading:18543281... | lld:pubmed |
pubmed-article:18543281 | pubmed:meshHeading | pubmed-meshheading:18543281... | lld:pubmed |
pubmed-article:18543281 | pubmed:meshHeading | pubmed-meshheading:18543281... | lld:pubmed |
pubmed-article:18543281 | pubmed:meshHeading | pubmed-meshheading:18543281... | lld:pubmed |
pubmed-article:18543281 | pubmed:meshHeading | pubmed-meshheading:18543281... | lld:pubmed |
pubmed-article:18543281 | pubmed:meshHeading | pubmed-meshheading:18543281... | lld:pubmed |
pubmed-article:18543281 | pubmed:meshHeading | pubmed-meshheading:18543281... | lld:pubmed |
pubmed-article:18543281 | pubmed:meshHeading | pubmed-meshheading:18543281... | lld:pubmed |
pubmed-article:18543281 | pubmed:meshHeading | pubmed-meshheading:18543281... | lld:pubmed |
pubmed-article:18543281 | pubmed:meshHeading | pubmed-meshheading:18543281... | lld:pubmed |
pubmed-article:18543281 | pubmed:meshHeading | pubmed-meshheading:18543281... | lld:pubmed |
pubmed-article:18543281 | pubmed:meshHeading | pubmed-meshheading:18543281... | lld:pubmed |
pubmed-article:18543281 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18543281 | pubmed:articleTitle | Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: implications for unilateral ablative therapy. | lld:pubmed |
pubmed-article:18543281 | pubmed:affiliation | Duke Prostate Center and Division of Urologic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA. polas001@mc.duke.edu | lld:pubmed |
pubmed-article:18543281 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18543281 | pubmed:publicationType | Comparative Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18543281 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18543281 | lld:pubmed |